The global Rabies Market size is expected to reach USD 2.38 billion by 2028 at a CAGR of 4.4% according to the latest report by Reports and Data. The most critical parameters influencing the global market growth are rising prevalence of infectious animal-transmitted diseases such as rabies and neglected tropical diseases (NTDs) worldwide, increasing awareness programs about infectious diseases, and growing number of rabies diagnostic tests.

Rabies is an infectious disease spread through animal bite or saliva and is characterized by symptoms such as excess salivation, headache, fever, muscle spasms, and mental instability. The most commonly known rabies diagnostic methods include Direct Fluorescent Antibody (DFA) test, Fluorescent Antibody Test (FAT), immunohistochemical tests, and amplification methods. These tests rapidly and accurately detect rabies virus antigens in brain tissue. Rabies diagnostic tests are generally performed using samples of bodily fluids such as saliva, serum, and spinal fluid of the infected person. Growth of the global Rabies market is propelled by rising adoption of advanced diagnostic solutions for rabies, increasing collaborations among research institutes and healthcare companies for the development of novel rabies detection assays, and increase in initiatives undertaken by healthcare organizations to control the spread of rabies. Growing adoption of cutting-edge point-of-care rabies diagnostic solutions worldwide is another major growth-inducing factor for this market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4037

Key Highlights of the Report:

• Based on diagnostic method, the fluorescent antibody test segment is expected to dominate in terms of revenue growth during the forecast period due to various favorable factors. This segment’s growth is principally attributed to rising prevalence of animal-borne diseases including rabies, increasing fluorescent antibody tests for rabies detection, and growing awareness about FAT’s advantages over other conventional methods including improved specificity and better sensitivity.
• The ELISA/immunohistochemistry segment is expected to reach highest revenue share over the forecast period. Spike in demand for ELISA/immunohistochemistry-based rabies diagnostic systems, increasing volumes of immunohistochemistry-based diagnostic tests, such as FAT and RREID, and cost-effectiveness of these tests are pivotal factors responsible for the growth of this segment over the forecast period.
• The North America Rabies market led in terms of market revenue share in 2020. Market growth in North America is accelerated by rising prevalence of rabies and other animal-transmitted diseases, growing number of rabies diagnostic tests, increased healthcare expenditures, and advanced healthcare infrastructure in the region. The Asia Pacific market is expected to demonstrate fastest revenue growth rate over the forecast period. Rising prevalence of neglected tropical diseases and increasing healthcare initiatives by governments to control the spread of rabies are expected to boost market growth in this region.

Key Players covered in this report are

Merck KGaA, Bio-Rad Laboratories, Inc., Norgen Biotek Corp., Express Biotech International Inc., Demeditec Diagnostics GmbH, Aviva Systems Biology Corporation, BioGen Technologies, Creative Diagnostics, MyBioSource.com, Abbexa Ltd., and BioNote, Inc.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4037

By Diagnostic Method (Revenue, USD Billion; 2018-2028)

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Histologic Examination
• Amplification Methods
• Serology Tests
• Others

By Technology Type (Revenue, USD Billion; 2018-2028)

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

By Provider (Revenue, USD Billion; 2018-2028)

• Hospitals
• Pharmacies
• Diagnostic centers
• Cancer Palliative care clinics
• Others

Key Regional Markets Covered in the Report:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)

Major Points covered in this report are as below:

• The Rabies industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Rabies Market report provides key statistics on the market status of the Rabies manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4037

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

Get Explore Latest Research Report by Reports and Data:

Immunoassay Analyzers Market @ https://www.biospace.com/article/immunoassay-analyzers-market-research-by-business-growth-analysis-industry-strategy-and-development-to-2027/

Acute Myeloid Leukemia Therapeutics Market @ https://www.biospace.com/article/acute-myeloid-leukemia-therapeutics-market-growth-prospects-competitive-analysis-upcoming-trend-and-forecast-2027/

Protein Stability Analysis Market @ https://www.biospace.com/article/protein-stability-analysis-market-current-trends-opportunities-and-growth-challenges-by-2028/

Recurrent Pericarditis Market @ https://www.biospace.com/article/north-america-is-expected-to-highest-industry-share-of-recurrent-pericarditis-market-across-the-world/

Scleroderma Market @ https://www.biospace.com/article/increase-in-the-prevalence-rate-of-disease-is-expected-to-drive-scleroderma-market-growth/

Doose Syndrome Treatment Market @ https://www.biospace.com/article/increasing-number-of-anxiety-disorders-changes-with-ages-is-expected-to-drive-growth-of-doose-syndrome-treatment-market/

Natural Language Processing (NLP) in Healthcare and Life Sciences Market @ https://www.biospace.com/article/natural-language-processing-nlp-in-healthcare-and-life-sciences-market-is-expected-to-reach-usd-4-799-6-million-by-2028-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com